Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

被引：0
作者：
Roisin Adams
Cathal Walsh
Douglas Veale
Barry Bresnihan
Oliver FitzGerald
Michael Barry
机构：
[1] St. James’ Hospital,National Centre for Pharmacoeconomics
[2] Trinity College Dublin,Department of Statistics
[3] Dublin Academic Healthcare,St. Vincent’s University Hospital
来源：
PharmacoEconomics | 2010年 / 28卷
关键词：
Rheumatoid Arthritis; Inflammatory Arthritis; Biological Therapy; Utility Score; Disease Activity Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The growth of economic analyses and in particular cost-utility analyses (CUA), which use the QALY as a measure of outcome, has heightened the interest in the methodologies used to calculate the QALY. The EQ-5D has produced quite different utility values from that of the SF-6D. This article seeks to understand these differences using a cohort of patients with inflammatory arthritis.
引用
收藏
页码：477 / 487
页数：10
相关论文
共 101 条
[11]  
Sherbourne CD(1999)Economic consequences of the progression of rheumatoid arthritis in Sweden Arthritis Rheum 42 347-56
[12]  
Fries JF(2004)Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK Rheumatology (Oxford) 43 62-72
[13]  
Spitz P(2004)The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis Health Technol Assess 8 1-91
[14]  
Kraines RG(2005)Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden Ann Rheum Dis 64 995-1002
[15]  
Bryan S(2006)Modeling and costeffectiveness analysis of etanercept in adultswith rheumatoid arthritis in Japan: a preliminary analysis Mod Rheumatol 16 77-84
[16]  
Longworth L(2007)Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis Arthritis Care Res 57 963-71
[17]  
Lamers L(2008)Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores Health Qual Life Outcomes 6 51-7
[18]  
Bouwmans C(2009)The episodic random utility model unifies time trade-off and discrete choice approaches in health state valuation Popul Health Metr 7 3-92
[19]  
van Straten A(1996)Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers Br J Rheumatol 35 4-5
[20]  
Gerard K(2002)The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 271-9
12345678910